NASDAQ:AVLN | Cash Flow Statement | Avalyn Pharma Inc.

Complete source-backed cash-flow history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$28.94M
2026-03-31-$26.87M-$29.89M$318,000.00$55.02M$14.86M
2025-06-30-$20.19M
2025-03-31-$17.5M-$19.28M$8,000.00$24.12M$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow